APA (7th ed.) Citation

Dejeu, D., Dejeu, P., Muresan, A., Bradea, P., & Dejeu, V. Investigation into the Use of Surufatinib and Donafenib as Novel Multi-Kinase Inhibitors Therapeutic Agents in Managing Advanced Differentiated Thyroid Cancer: A Systematic Review. MDPI AG.

Chicago Style (17th ed.) Citation

Dejeu, Danut, Paula Dejeu, Anita Muresan, Paula Bradea, and Viorel Dejeu. Investigation into the Use of Surufatinib and Donafenib as Novel Multi-Kinase Inhibitors Therapeutic Agents in Managing Advanced Differentiated Thyroid Cancer: A Systematic Review. MDPI AG.

MLA (9th ed.) Citation

Dejeu, Danut, et al. Investigation into the Use of Surufatinib and Donafenib as Novel Multi-Kinase Inhibitors Therapeutic Agents in Managing Advanced Differentiated Thyroid Cancer: A Systematic Review. MDPI AG.